home > events calendar > more about event



1-2 November 2018
Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.

The exhibition brings together all the key suppliers to the region’s pharmaceutical manufacturing base, exhibitors presenting a full range of APIs, excipients, and drug formulations; pharmaceutical packaging solutions; processing machinery and equipment; laboratory equipment; clean room technology; and much, much more!

The exhibition attracts decision makers from all the leading pharmaceutical manufacturers in the region and from across Africa, and provides a forum for manufacturers and their suppliers to forge long-standing, mutually beneficial partnerships to ensure future commercial success.
phone 0044 (0) 203 198 9621
email Gallagher Convention Centre, Midrand, South Africa
Print this page
Send to a friend
Industry Events

Vaccine Manufacturing

23-25 April 2018, RAI, Amsterdam

Changing the shape of vaccine development, manufacturing and delivery.
More info >>

Banner of ChinaBio_Events_102 on Samedan
White Papers


Weibel CDS AG

Safer, easier and faster drug delivery – Weibel CDS AG, Switzerland develops and produces innovative, user friendly, application oriented injections systems and devices. The SuperCapSyringe® product family upgrades your vial practically to a prefilled syringe. Based on a modular design, the syringe is fully adaptable to your application needs. It is supplied in different sizes and, as a novelty, with staked needles including a passive safety device.
More info >>

News and Press Releases

MSD launches ONTRUZANT®▼ (biosimilar trastuzumab), a biosimilar of intravenous HERCEPTIN®, which is the first breast cancer biosimilar in the UK

Hoddesdon, [8th March 2018] – MSD today announced the launch of ONTRUZANT®▼, (trastuzumab), a biosimilar referencing HERCEPTIN®* (trastuzumab/TRZ), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. This was the first trastuzumab biosimilar to receive regulatory approval in Europe and is the first to launch in the UK.1
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement